Impact of macular fluid features on outcomes of anti-vascular endothelial growth factor treatment for type 3 macular neovascularization

We evaluated the impact of macular fluid features on visual and anatomical outcomes in type 3 macular neovascularization (MNV) patients treated with anti-vascular endothelial growth factor (VEGF). We retrospectively enrolled 89 eyes with type 3 MNV with at least 12 months of follow-up. All patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Wontae, Yoon, Jihyun, Na, Seung Kwan, Lee, Jihyun, Kim, Jaemin, Kim, Jong Woo, Cho, Han Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655104/
https://www.ncbi.nlm.nih.gov/pubmed/34880302
http://dx.doi.org/10.1038/s41598-021-03053-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655104/
https://www.ncbi.nlm.nih.gov/pubmed/34880302
http://dx.doi.org/10.1038/s41598-021-03053-w

Ejemplares similares